Financial Performance - Total revenue for the year ended December 31, 2023, reached RMB 2,145,068,000, representing a year-on-year increase of 31.2%[2] - Net profit for the year was RMB 230,139,000, a significant increase of 108.2% compared to RMB 110,532,000 in 2022[2] - The gross profit margin improved to 45.6%, up from 43.9% in the previous year[2] - The adjusted net profit (non-HKFRS measure) was RMB 241,039,000, up 53.2% from RMB 157,359,000 in 2022[4] - Total revenue for the company increased by 31.2% from RMB 1,635.4 million in 2022 to RMB 2,145.1 million in 2023[25] - The company reported a net profit of RMB 230,139 thousand for the year ended December 31, 2023, compared to RMB 110,532 thousand in 2022, which is an increase of 108.1%[49] - The gross profit for the year ended December 31, 2023, was RMB 977,102 thousand, up from RMB 717,842 thousand in 2022, indicating a growth of 36.2%[48] - Net profit surged by 108.2% from RMB 110.5 million in 2022 to RMB 230.1 million in 2023, with net profit margin increasing from 6.8% to 10.7%[40] Revenue Breakdown - Revenue from beauty and health services reached RMB 1,193,675,000, accounting for 55.6% of total revenue, with a year-on-year growth of 26.1%[8] - Medical beauty services generated RMB 850,356,000 in revenue, reflecting a 37.1% increase compared to the previous year[8] - Revenue from beauty and wellness services was RMB 1.19 billion in 2023, a year-on-year increase of 26.1%[12] - Revenue from medical beauty services was RMB 850 million in 2023, reflecting a year-on-year growth of 37.1%[15] - Revenue from sub-health medical services reached RMB 101,037,000, marking a 47.6% increase year-on-year[8] - Revenue from beauty and wellness services through direct stores increased by 29.2% from RMB 835.6 million in 2022 to RMB 1,079.9 million in 2023, driven by brand influence and digital tools enhancing customer acquisition efficiency[27] - Revenue from sub-health medical services rose by 47.6% from RMB 68.5 million in 2022 to RMB 101.0 million in 2023, reflecting heightened customer health awareness post-pandemic[29] Membership and Customer Engagement - Active members in direct-operated stores increased to 93,667, up 19.6% from 78,318 in 2022[2] - The number of active members at direct-operated stores reached 94,000 in 2023, representing a year-on-year growth of 19.6%[9] - The average annual spending per active member at direct-operated stores was RMB 20,695, an increase of RMB 2,109 compared to 2022[9] - Active membership in sub-health medical services increased by 36.5% year-on-year to 4,191 members, with each member visiting an average of 4.0 times per year, up by 0.5 visits compared to 2022[18][19] - The average annual spending per active member in medical beauty services was RMB 34,597, an increase of RMB 1,493 compared to 2022[15] Operational Expansion - The company expanded its store network to over 400 stores by December 31, 2023, including 201 direct-operated and 199 franchise stores[10] - In 2023, the company received 1.26 million customer visits at direct-operated stores, a year-on-year increase of 33.1%[9] - The company plans to expand its store count and increase market share in core regions while exploring acquisition opportunities in high-performing franchise areas[23][24] Cash and Financial Position - Cash and cash equivalents reached RMB 1.57 billion by December 31, 2023, an increase of RMB 660 million year-on-year[10] - The total assets as of December 31, 2023, amounted to RMB 3,302,006 thousand, a significant increase from RMB 2,495,389 thousand in 2022, representing a growth of 32.3%[50] - The company had cash and cash equivalents of RMB 224,277 thousand at the end of 2023, compared to RMB 164,120 thousand at the end of 2022, marking a 36.7% increase[42] - The total cash and bank balances as of December 31, 2023, were RMB 619,657,000, significantly higher than RMB 294,050,000 as of December 31, 2022, marking an increase of 110.7%[81] Strategic Initiatives - Strategic acquisitions and investments were emphasized as a key strategy for business expansion, including a strategic agreement with Chengdu Youlan and the acquisition of Hangzhou Yanguangfang[21][22] - The company aims to enhance its digital capabilities to improve operational efficiency and decision-making processes[20][24] - The company developed and launched 33 important information management systems, with 22 of them being self-developed[20] Corporate Governance and Compliance - The company has complied with all code provisions under the corporate governance code during the reporting period[90] - The audit committee, consisting of one non-executive director and two independent non-executive directors, has been established to oversee financial reporting and internal controls[95] - The company adheres to the corporate governance code as per the listing rules[101] Shareholder Returns - The company proposed a final dividend of HKD 0.47 per share, totaling approximately HKD 110.8 million, subject to shareholder approval[5] - The total dividends declared to shareholders for the year ended December 31, 2023, amounted to RMB 86,313,000, a decrease of 56.5% from RMB 198,742,000 in 2022[74] - The proposed final dividend per share for the year ended December 31, 2023, is HKD 0.47, compared to HKD 0.39 in 2022, representing an increase of 20.5%[75]
美丽田园医疗健康(02373) - 2023 - 年度业绩